Project Details
Description
Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage
| Status | Active |
|---|---|
| Effective start/end date | 11/12/24 → 5/31/29 |
Funding
- NATIONAL MARROW DONOR PROGRAM
- NIH Nat'l Inst of Allergy & Infect Dis
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.